Results 41 to 50 of about 188,535 (344)

The use of ultrasound in clinical setting for children affected by NAFLD. is it safe and accurate? [PDF]

open access: yes, 2011
Non-alcoholic fatty liver disease (NAFLD) has become over the last decade the most common form of chronic liver disease in children and adults. Thus, establishing the diagnosis of NAFLD is of utmost importance and represents a major challenge as the ...
Nobili V   +4 more
core   +1 more source

Heterogeneity of non‐alcoholic fatty liver disease [PDF]

open access: yesLiver International, 2015
See Article on Page ...
Yki‐Järvinen, Hannele   +1 more
openaire   +2 more sources

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease

open access: yesJournal of Personalized Medicine, 2023
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, and is related to fatal and non-fatal liver, metabolic, and cardiovascular complications. Its non-invasive diagnosis and effective treatment remain an unmet clinical need.
Laura Valenzuela-Vallejo   +2 more
openaire   +3 more sources

Chemokines modulate chondrocyte homeostasis: implications in osteoarthritis [PDF]

open access: yes, 2004
Non-alcoholic steatohepatitis (NASH) is an underdiagnosed liver disease characterized by steatosis, necroinflammation and fibrosis. This disease may eventually develop into cirrhosis and hepatocellular carcinoma.
Rai, M.F., Cotton, R., Sandell, L.J.
core   +1 more source

Diagnosis of Non-alcoholic fatty liver disease

open access: yesJournal of Pathology of Nepal, 2016
Non Alcoholic Fatty Liver Disease is the deposition of fat in liver in absence of excessive of alcohol consumption. Non Alcoholic Fatty Liver Disease ranges from simple steatosis to Nonalcoholic steatohepatitis and cirrhosis.
Geetika K.C.
doaj   +1 more source

Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate. [PDF]

open access: yesPLoS ONE, 2015
Toll-like receptor 4 and proinflammatory cytokines play a central role in the progression of nonalcoholic fatty liver disease. We investigated IL-1, IL-6 and TNFα production and toll-like receptor 4 in both--obese and lean patients with non-alcoholic ...
Agnieszka Zwolak   +4 more
doaj   +1 more source

Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study

open access: yesBMC Medicine, 2022
Background The relationship between non-alcoholic fatty liver degree as well as non-alcoholic fatty liver disease (NAFLD) and irritable bowel syndrome (IBS) remains poorly understood.
Shanshan Wu   +6 more
doaj   +1 more source

Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study

open access: yesJournal of Nepal Medical Association, 2021
Introduction: Non-alcoholic fatty liver disease is fatty infiltration of the liver in the absence of other causes of steatosis. It is strongly associated with central adiposity, high body mass index, insulin resistance states, hypertension ...
Bom BC   +4 more
doaj   +1 more source

The Role of Insulin Resistance in Diabetic Patients with Chronic Liver Disease [PDF]

open access: yes, 2008
Background: The association between diabetes and chronic liver disease has been well documented. However, the mechanism remains unknown. The aim of this study was to investigate the insulin resistance in chronic liver disease and normal liver in diabetic
Bayupurnama, P. (Putut)   +3 more
core   +1 more source

Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease. [PDF]

open access: yesPLoS ONE, 2016
Although non-alcoholic and alcoholic fatty liver disease have been intensively studied, concerning pathophysiological mechanisms are still incompletely understood.
Vera H I Fengler   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy